Tue Sep 23 01:48:42 UTC 2025: **News Article Summary:**
The Trump administration is facing widespread criticism for its stance on prenatal care and vaccinations. President Trump has advised pregnant people to limit Tylenol use due to an unproven link to autism, despite medical consensus that it is a safe pain reliever during pregnancy. He also suggested delaying the Hepatitis B vaccine for newborns until age 12, contradicting decades of established medical practice aimed at preventing maternal transmission of the disease. These statements come as the administration, led by Robert F. Kennedy Jr., focuses on identifying the cause of autism, a complex condition largely believed to be genetic. Kennedy Jr. has promoted leucovorin as a potential autism therapy, and the FDA has approved its tablet form for children with cerebral folate deficiency. Experts have expressed concern that the administration’s efforts are rushed and could cause confusion and fear, particularly regarding the alleged link between Tylenol and autism, which is based on limited and contested research.
**News Article:**
**Trump Administration Sparks Controversy with Advice on Tylenol, Vaccines**
WASHINGTON – The Trump administration is under fire for issuing controversial recommendations regarding prenatal care and childhood vaccinations, diverging sharply from established medical consensus.
President Trump on Monday advised pregnant people to limit their use of Tylenol, citing an unsubstantiated link to autism. This recommendation contradicts the widespread medical view that acetaminophen, the active ingredient in Tylenol, is one of the safest pain relief options during pregnancy. Medical professionals stress that uncontrolled pain and fever can pose risks to both the mother and developing fetus.
In addition, Trump suggested delaying the Hepatitis B vaccine for newborns until the age of 12, a statement that flies in the face of decades of medical consensus that recommends vaccination within the first 24 hours of life to prevent maternal transmission of the disease. This stance echoes anti-vaccine rhetoric and has been widely condemned by medical experts.
These pronouncements come as the White House, spearheaded by health chief Robert F. Kennedy Jr., has pledged to revolutionize health in the United States by uncovering the cause of autism. Kennedy, known for his anti-vaccine views, has promoted leucovorin as a potential therapy for autism, and the FDA has approved its tablet form for certain children with cerebral folate deficiency.
The administration’s focus on acetaminophen and autism has drawn sharp criticism from medical organizations and researchers. While a recent review suggested a possible link between Tylenol exposure and autism, other studies have found contradictory results. Experts caution that more research is needed and that pregnant people should not stop taking medication without consulting their doctors.
“The Secretary Kennedy’s announcement will cause confusion and fear,” stated the Coalition of Autism Scientists, highlighting the potentially dangerous implications of claiming links between potential exposures and autism when the science is far more nuanced and uncertain.
Experts are concerned that the administration’s approach to autism research is rushed and could lead to misinformation and anxiety among the public. They emphasize the need for rigorous, long-term studies to understand the complex interplay of genetic and environmental factors in autism development.
First Piper 